Volume CT Dose Index

Volume CT Dose Index (CTDIvol) is a metric used to represent the average dose-per-unit-volume in a CT scan. It is calculated by dividing the volume-weighted CTDI (CTDIw) by the overlap factor. This indicator originates from international standards like IEC 60601-2-44 and is used to assess the radiation dose distribution in CT imaging. In the context of enterprise risk management, CTDIvol is a critical input for hazard identification and risk assessment, ensuring medical devices adhere to the ALARA principle. Unlike DLP (Dose Length Product), which represents total dose, CTDIvol focuses on the dose per unit volume, making it essential for optimizing scan parameters. For companies, this data is a core component of pre-market verification and regulatory compliance documentation. Taiwan's Medical Device Act requires manufacturers to provide technical documentation, where CTDIvol serves as primary evidence of radiation safety compliance.

In medical device risk management, CTDIvol application follows three steps: First, establishing benchmarks based on IEC 60601-2-44 standards during the design phase. Second, executing Verification and Validation (V&V) to ensure the CTDIvol values meet the safety-by-design requirements. Third, implementing post-market surveillance to monitor real-world dose-per-unit-volume--and compare it with local Diagnostic Reference Levels (DRLs). A practical example: a Taiwanese CT manufacturer implemented a CTDIvol monitoring dashboard, which led to a 25% reduction in clinical safety complaints and a 100% pass rate in ISO 13485 audits within the first year. Key performance indicators (KPIs) include compliance rate with DRLs (target >95%) and reduction in radiation-related adverse events (target <0.1%).

Taiwanese enterprises typically face three challenges: regulatory interpretation differences, equipment calibration needs, and cross-departmental silos. Regulatory requirements from the Taiwan Food and Drug Administration (TFDA) regarding dose-related technical documentation can be stringent. To overcome this, companies should be closely closely aligned with the latest TFDA guidance and international standards. Equipment calibration challenges can be addressed by partnering with certified calibration laboratories to ensure CTDIvol accuracy. Finally, the siloing of technical and clinical teams can be solved by establishing a cross-functional Risk Management Committee. A phased implementation plan—starting with a 6-month pilot program—is recommended to ensure sustainable compliance and operational efficiency.

Winners Consulting Services Co., Ltd. specializes in Volume CT Dose Index-related regulatory compliance for Taiwan enterprises, delivering compliant management systems within 90 days. We have assisted over 100 companies in achieving international standards. Request a free mechanism diagnosis: https://winners.com.tw/contact